{
  "company": {
    "name": "One-carbon Therapeutics",
    "website": "https://one-carbon.com/",
    "record": "https://startuphistory.org/c/one-carbon.com"
  },
  "status": null,
  "history_since": "2021-10-28T02:39:34.000Z",
  "baseline": {
    "snapshot_id": "8baf7c72d13c18a1f075d3b1bb43e401809c0cd4bb58dd9ff99d67be4cf79706",
    "observed_at": "2023-02-08T07:23:27.000Z",
    "headline": null,
    "description": "One-carbon therapeutics AB is tackling the most difficult to treat cancers, inflammation and autoimmune diseases by targeting the disease specific one-carbon metabolism pathway, representing a novel w",
    "evidence": "https://web.archive.org/web/20230208072327/https://one-carbon.com/",
    "evidence_kind": "internet_archive",
    "facts": null,
    "basis": "first_observation",
    "is_change": false
  },
  "live_captures": 1,
  "last_checked": "2026-11-06T19:47:28.046Z",
  "live_status": null,
  "messaging": [
    {
      "quote_observed_at": "2026-11-06T19:47:28.046Z",
      "variants": [
        {
          "headline": "Pioneering novel therapy that exploit cancer’s oncogene addiction",
          "subhead": "One-carbon therapeutics AB is tackling the most difficult to treat cancers, inflammation and autoimmune diseases by targeting the disease specific one-carbon metabolism pathway, representing a novel w",
          "observed_at": "2026-11-06T19:47:28.046Z",
          "evidence": "https://one-carbon.com/",
          "evidence_kind": "live_capture"
        }
      ],
      "headline": "Pioneering novel therapy that exploit cancer’s oncogene addiction",
      "subhead": "One-carbon therapeutics AB is tackling the most difficult to treat cancers, inflammation and autoimmune diseases by targeting the disease specific one-carbon metabolism pathway, representing a novel w",
      "from": "2026-11-06T19:47:28.046Z",
      "to": "2026-11-06T19:47:28.046Z",
      "captures": 1,
      "evidence": "https://one-carbon.com/",
      "evidence_kind": "live_capture",
      "seen": {
        "on": "2026-11-06T19:47:28.046Z"
      },
      "current": true
    }
  ],
  "changes": [
    {
      "n": 1,
      "id": "page-5b25f898eb4441d09b43c9e4ba1cefcb28d2106c82d981b64d891ca27b85d7fe:310e428de6c884add59516816fa3a9fd5132cd95ba2a4b5de62756949209679d:funding:0e3728b40a602c4d",
      "before_evidence": "https://web.archive.org/web/20250718232616/https://one-carbon.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "funding",
      "label": "Funding",
      "summary": "Announced on its homepage: “Learn more Latest news One-carbon Therapeutics announces oversubscribed private placement financing of SEK 153 million (€13.9 million) So…”.",
      "between": {
        "from": "2025-07-18T23:26:16.000Z",
        "to": "2026-01-04T23:26:15.000Z"
      },
      "evidence": "https://web.archive.org/web/20260104232615/https://one-carbon.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": "https://startuphistory.org/t/announced-funding"
    },
    {
      "n": 2,
      "id": "page-310e428de6c884add59516816fa3a9fd5132cd95ba2a4b5de62756949209679d:d6595d03b098db6e70f6e875bb08d27d5139a999b57cf5dcfe463b5ab3fc5de8:headline:8d18c08a91fe51bb",
      "before_evidence": "https://web.archive.org/web/20260104232615/https://one-carbon.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "headline",
      "label": "Headline",
      "summary": "Changed its homepage headline from “One-Carbon Therapeutics” to “Pioneering novel therapy that exploit cancer’s oncogene addiction”.",
      "between": {
        "from": "2026-01-04T23:26:15.000Z",
        "to": "2026-11-06T19:47:28.046Z"
      },
      "evidence": "https://one-carbon.com/",
      "evidence_kind": "live_capture",
      "basis": "page_facts",
      "topic": null
    }
  ],
  "update": {
    "headline": "One-carbon Therapeutics updates homepage and announces financing",
    "summary": "One-carbon Therapeutics highlights a new homepage headline and has announced an oversubscribed private placement financing. The company now describes itself as pioneering a novel cancer therapy approach.",
    "points": [
      {
        "text": "Between July 2025 and January 2026, One-carbon Therapeutics announced on its homepage an oversubscribed private placement financing of SEK 153 million (€13.9 million).",
        "kind": "fact",
        "changes": [
          1
        ]
      },
      {
        "text": "Between January 2026 and November 2026, One-carbon Therapeutics changed its homepage headline to say it is “pioneering novel therapy that exploit cancer’s oncogene addiction”.",
        "kind": "fact",
        "changes": [
          2
        ]
      },
      {
        "text": "The combination of an oversubscribed private placement financing and a new oncology-focused homepage headline between July 2025 and November 2026 may suggest increasing emphasis on developing novel cancer therapies.",
        "kind": "interpretation",
        "changes": [
          1,
          2
        ]
      }
    ],
    "written_at": "2026-11-07T14:57:46.089Z",
    "basis": "ai_analysis",
    "model": "gpt-5.1-2025-11-13"
  },
  "method": {
    "version": "messaging-v1",
    "description": "https://startuphistory.org/method"
  },
  "license": "CC-BY-4.0",
  "cite": "StartupHistory, “One-carbon Therapeutics” company record, https://startuphistory.org/c/one-carbon.com"
}